Drug Profile
SAR 97276
Alternative Names: Albitiazolium bromide; SAR-97276; SAR97276ALatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Developer Sanofi
- Class Alcohols; Alkanes; Antimalarials; Quaternary ammonium compounds; Small molecules; Thiazoles
- Mechanism of Action Cholinergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Malaria
Most Recent Events
- 31 Oct 2011 Phase-II clinical trials in Malaria in Benin, Burkina Faso, Kenya and Gabon (IM) (NCT01445938)
- 30 Jul 2010 Phase-I clinical trials in Malaria in Benin, Burkina Faso, Gabon and Tanzania (IM)
- 30 Jul 2010 Phase-I clinical trials in Malaria in Benin, Burkina Faso, Gabon and Tanzania (IV)